This is because many have classified the nutrient as a wonder when it comes to fat loss
Glucagon-like peptide-1 class drugs show clear protective effects in Parkinsons and Alzheimers disease clinical trials: A revolution in the making
Int J Obes Relat Metab Disord 23(3):304311 Nauck MA, Niedereichholz U, Ettler R, Holst JJ, Orskov C, Ritzel R et al (1997) Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans
Research shows secondary IGF-1 production through hepatic pathways
(Myhre passed away in 2012, but the record Magness asked about was from 2002, a year when Myhre was given an award by Nike for his work, according to an obituary.) Salazar said Myhre was crazy and he must be mixing it up with something else, Magness says
[Abstract]2021 Nov;77(11):5294-5303